Rheumatoid Arthritis News
| Jul 24, 2008 – SOURCE: DGNews | |||
 |
|
TopAbstracts in Rheumatoid Arthritis 07/24/2008 | |
| TopAbstracts - Past 14 days |
|||
| Jul 23, 2008 – SOURCE: Annals of Thoracic Surgery | |||
|
|
Mitral valve replacement in rheumatic patients: effects of chordal preservation | |
| BACKGROUND: Subvalvular preservation is beneficial in patients undergoing mitral valve replacement, especially in degenerative mitral regurgitation. Its feasibility and benefit is less evident in rheumatic disease. Our aim was to study the impact of prese | |||
| Jul 22, 2008 – SOURCE: DGNews | |||
|
|
New ACR Guidelines Update Strategies for Treating RA | |
| BIRMINGHAM, Ala -- July 22, 2008 -- Proven combinations of medicines and the introduction of new antiarthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumato | |||
| Jul 21, 2008 – SOURCE: Annals of the Rheumatic Diseases (ARD Online) | |||
|
|
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis | |
| OBJECTIVES: Recent evidence suggests that distinction of subsets of rheumatoid arthritis (RA) depending on anti-cyclic citrullinated peptide antibody (anti-CCP) status may be helpful in distinguishing distinct aetiopathologies and in predicting course of | |||
| Jul 21, 2008 – SOURCE: Journal of Rheumatology | |||
|
|
Cost-Effectiveness of Abatacept in Patients with Moderately to Severely Active Rheumatoid Arthritis and Inadequate Response to Tumor Necrosis Factor-alpha Antagonists | |
| OBJECTIVE: To assess cost-effectiveness of abatacept in patients with rheumatoid arthritis (RA) with inadequate response to tumor necrosis factor-alpha antagonists (anti-TNF). METHODS: We developed a simulation model to depict progression of disability [i | |||
| Jul 21, 2008 – SOURCE: Archives of Orthopaedic and Trauma Surgery | |||
|
|
Similar results with 21 Kudo and 21 Souter-Strathclyde total elbow arthroplasties in patients with rheumatoid arthritis | |
| INTRODUCTION: The results of different prostheses used for total elbow arthroplasty (TEA) in rheumatoid arthritis (RA) have been reported in only a few studies. Small differences in survival or function between implants have been reported. We retrospectiv | |||
| Jul 21, 2008 – SOURCE: Lancet | |||
|
|
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial | |
| BACKGROUND: Remission and radiographic non-progression are goals in the treatment of early rheumatoid arthritis. The aim of the combination of methotrexate and etanercept in active early rheumatoid arthritis (COMET) trial is to compare remission and radio | |||
| Jul 21, 2008 – SOURCE: Journal of Rheumatology | |||
|
|
Single Nucleotide Polymorphism of COL6A1 in Patients with Ankylosing Spondylitis | |
| To investigate the genetic association between ankylosing spondylitis (AS) and single nucleotide polymorphisms (SNP) of collagen 6A1 gene (COL6A1), the candidate gene for ossification of the posterior longitudinal ligament. METHODS: One-hundred thirty Kor | |||
| Jul 21, 2008 – SOURCE: Journal of Rheumatology | |||
|
|
Patients with Rheumatoid Arthritis Treated with Methotrexate (MTX): Concentrations of Steady-state Erythrocyte MTX Correlate to Plasma Concentrations and Clinical Efficacy | |
| To investigate the accumulation of methotrexate (MTX) in circulating erythrocytes and the association with pharmacokinetic variables, weekly dose, and clinical efficacy in 2 cohorts of patients with chronic active rheumatoid arthritis (RA) undergoing MTX | |||
| Jul 21, 2008 – SOURCE: Journal of Rheumatology | |||
|
|
Tumor Necrosis Factor-alpha -1031 T/C Polymorphism Is Associated with Smaller and More Proatherogenic Low Density Lipoprotein Particles in Patients with Rheumatoid Arthritis | |
| OBJECTIVE: To study, in patients with rheumatoid arthritis (RA), the association between the tumor necrosis factor (TNF)-alpha -1031 T/C polymorphism and quantitative and qualitative low density lipoprotein (LDL) characteristics.METHODS: From a sample of | |||
